Ingrid M Lizarraga1, Amanda R Kahl2, Ellie Jacoby3, Mary E Charlton2, Charles F Lynch2, Sonia L Sugg4. 1. Department of Surgery, University of Iowa Hospitals and Clinics, 4636 JCP, 200 Hawkins Dr, Iowa City, IA, 52246, USA. ingrid-lizarraga@uiowa.edu. 2. College of Public Heath, University of Iowa, Iowa, USA. 3. School of Medicine, Vanderbilt University, Nashville, USA. 4. Department of Surgery, University of Iowa Hospitals and Clinics, 4636 JCP, 200 Hawkins Dr, Iowa City, IA, 52246, USA.
Abstract
PURPOSE: Iowa is among several rural Midwestern states with the highest proportions of contralateral prophylactic mastectomy (CPM) in women < 45 years of age. We evaluated the role of rurality and travel distance in these surgical patterns. METHODS: Women with unilateral breast cancer (2007-2017) were identified using Iowa Cancer Registry records. Patients and treating hospitals were classified as metro, nonmetro, and rural based on Rural-Urban Continuum Codes. Differences in patient, tumor, and treatment characteristics and median travel distance (MTD) were compared. Characteristics associated with CPM were evaluated with multivariate logistic regression. RESULTS: 22,158 women were identified: 57% metro, 26% nonmetro and 18% rural. Young rural women had the highest proportion of CPM (52%, 39% and 40% for rural, metro, nonmetro women < 40 years). Half of all rural women had surgery at metro hospitals; these women had the longest MTD (62 miles). Among all women treated at metro hospitals, rural women had the highest proportion of CPM (17% rural vs 14% metro/nonmetro, p = 0.007). On multivariate analysis, traveling ≥ 50 miles (ORs 1.43-2.34) and rural residence (OR = 1.29) were independently predictive of CPM. Other risk factors were young age (< 40 years: OR = 7.28, 95% CI 5.97-8.88) and surgery at a metro hospital that offers reconstruction (OR = 2.30, 95% CI 1.65-3.21) and is not NCI-designated (OR = 2.34, 95% CI 1.92-2.86). CONCLUSION: There is an unexpectedly high proportion of CPM in young rural women in Iowa, and travel distance and availability of reconstructive services likely influence decision-making. Improving access to multidisciplinary care in rural states may help optimize decision-making.
PURPOSE: Iowa is among several rural Midwestern states with the highest proportions of contralateral prophylactic mastectomy (CPM) in women < 45 years of age. We evaluated the role of rurality and travel distance in these surgical patterns. METHODS: Women with unilateral breast cancer (2007-2017) were identified using Iowa Cancer Registry records. Patients and treating hospitals were classified as metro, nonmetro, and rural based on Rural-Urban Continuum Codes. Differences in patient, tumor, and treatment characteristics and median travel distance (MTD) were compared. Characteristics associated with CPM were evaluated with multivariate logistic regression. RESULTS: 22,158 women were identified: 57% metro, 26% nonmetro and 18% rural. Young rural women had the highest proportion of CPM (52%, 39% and 40% for rural, metro, nonmetro women < 40 years). Half of all rural women had surgery at metro hospitals; these women had the longest MTD (62 miles). Among all women treated at metro hospitals, rural women had the highest proportion of CPM (17% rural vs 14% metro/nonmetro, p = 0.007). On multivariate analysis, traveling ≥ 50 miles (ORs 1.43-2.34) and rural residence (OR = 1.29) were independently predictive of CPM. Other risk factors were young age (< 40 years: OR = 7.28, 95% CI 5.97-8.88) and surgery at a metro hospital that offers reconstruction (OR = 2.30, 95% CI 1.65-3.21) and is not NCI-designated (OR = 2.34, 95% CI 1.92-2.86). CONCLUSION: There is an unexpectedly high proportion of CPM in young rural women in Iowa, and travel distance and availability of reconstructive services likely influence decision-making. Improving access to multidisciplinary care in rural states may help optimize decision-making.
Entities:
Keywords:
Breast cancer; Contralateral prophylactic mastectomy; Rural; Travel distance
Authors: Laura Grimmer; Erik Liederbach; Jose Velasco; Catherine Pesce; Chi-Hsiung Wang; Katharine Yao Journal: J Am Coll Surg Date: 2015-04-23 Impact factor: 6.113
Authors: Frances C Wright; Nicole J Look Hong; May Lynn Quan; Kaitlyn Beyfuss; Sara Temple; Andrea Covelli; Nancy Baxter; Anna R Gagliardi Journal: Ann Surg Date: 2018-02 Impact factor: 12.969
Authors: Allison C Knutson; Erica J McNamara; Daniel P McKellar; Cary S Kaufman; David P Winchester Journal: J Surg Oncol Date: 2014-07-08 Impact factor: 3.454
Authors: John D Birkmeyer; Bradley N Reames; Peter McCulloch; Andrew J Carr; W Bruce Campbell; John E Wennberg Journal: Lancet Date: 2013-09-28 Impact factor: 79.321
Authors: Kathryn E Weaver; Nynikka Palmer; Lingyi Lu; L Douglas Case; Ann M Geiger Journal: Cancer Causes Control Date: 2013-05-16 Impact factor: 2.506
Authors: Chun Chieh Lin; Suanna S Bruinooge; M Kelsey Kirkwood; Christine Olsen; Ahmedin Jemal; Dean Bajorin; Sharon H Giordano; Michael Goldstein; B Ashleigh Guadagnolo; Michael Kosty; Shane Hopkins; James B Yu; Anna Arnone; Amy Hanley; Stephanie Stevens; Dawn L Hershman Journal: J Clin Oncol Date: 2015-08-24 Impact factor: 44.544
Authors: Dadrie F Baptiste; Erina L MacGeorge; Maria K Venetis; Ashton Mouton; L Brooke Friley; Rebekah Pastor; Kristen Hatten; Janaka Lagoo; Susan E Clare; Monet W Bowling Journal: BMC Womens Health Date: 2017-02-01 Impact factor: 2.809
Authors: Danielle Riley; Elizabeth A Chrischilles; Ingrid M Lizarraga; Mary Charlton; Brian J Smith; Charles F Lynch Journal: Breast Cancer Res Treat Date: 2022-01-24 Impact factor: 4.872